100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Summary NR565 / NR 565 Week 5 Study Guide Advanced Pharmacology Fundamentals Final Exam Study Guide (Latest 2022/2023) $17.49   Add to cart

Summary

Summary NR565 / NR 565 Week 5 Study Guide Advanced Pharmacology Fundamentals Final Exam Study Guide (Latest 2022/2023)

 0 view  0 purchase
  • Course
  • Institution

NR565 / NR 565 Week 5 Study Guide Advanced Pharmacology Fundamentals Final Exam Study Guide (Latest 2022/2023)

Preview 3 out of 21  pages

  • April 6, 2022
  • 21
  • 2022/2023
  • Summary
avatar-seller
NR 565 Week 5 Chapter 26: Drugs used in treating eye &
ear disorders
Contraindications for topical beta blockers Beta blockers
 Suppress conduction through the atrioventricular (AV) node; therefore, topical beta
blockers are contraindicated in patients with bradycardia or advanced AV block.
 Do not use in patients with compromised ventricular dysfunction, cardiogenic shock, or
with systolic congestive HF
 D/c at first sign of cardiac failure
 Contraindicated with hypotension
 Use with caution: poorly controlled DM and hyperthyroidism
 Surgical patients should be monitored closely for cardiac failure
o Withdraw before surgery 2 days prior
 Contraindicated with Raynaud’s disease or PVD, CVD
 Preg cat C: fetal anomalies and fetotoxicity in animal studies

Prophylaxis for opthalmia neonatorum

 Common patient group: infants younger than 1 month who presents with conjunctivitis
should have Gram's stain, antigen detection tests, and cultures of the eye discharge to
rule out gonococcal, chlamydial, or HSV origin.

 Chlamydia is the most common cause of neonatal conjunctivitis

 Gonococcal conjunctivitis is the most serious cause of ophthalmia neonatorum owing to
concerns about the bacteria causing blindness

 Prophylaxis: Administration of antibiotic eye medication within 1 hour of delivery

 Erythromycin ointment 0.5% (0.25 to 0.5-inch ribbon in each eye)

 Chlamydial conjunctivitis is not prevented by prophylactic use of erythromycin at birth
therefore any mucopurulent eye discharge in the first few weeks of life should be
evaluated for chlamydia.

Glaucoma: Treatment, dosing, and patient education:

 IOP damages the optic nerve

 Leading cause of blindness worldwide

 6-8 times more likely in African Americans than Caucations

,  Antiglaucoma medications are prescribed by ophthalmologists. Dosage is determined by
the clinical condition of the patient.

Treatment and dosing
 Current medical therapies are aimed at
o decreasing the production of aqueous humor at the ciliary body and
o Increasing the outflow of this fluid from the angle structures
 Requires evaluation and treatment by an ophthalmologist
o FNPs need to be aware of the medications prescribed, drug interactions, and ADRs
 Antiglaucoma agents are prescribed by ophthalmologists and dosage is determined by
the clinical condition of the patient
 Four categories: Beta Blockers, adrenergic agonists, miotics, and carbonic anhydrase
(CA) inhibitors
o Beta Blockers:
 Betaxolol, carteolol, metipranolol, levobunolol, timolol
o Adrenergic Agonists
 Apraclonidine, brimonidine
o Miotics
 Carbachol, pilocarpine, echothiophate
o Carbonic Anhydrase Inhibitors
 Acetazoleamide, brinzolamide, dorzolamide, methazolamide
Patient education
 The patient should be instructed to administer the medication exactly as the
ophthalmologist has prescribed
 Abruptly stopping the medication can increase adverse effects.
 The patient should have been instructed by the ophthalmologist regarding the adverse
effects of the medication.
o Reinforcement may be necessary. If the patient is experiencing adverse effects
from the medication, the primary care provider can facilitate a referral back to the
ophthalmologist.


Allergic or Vernal conjunctivitis: Treatment, dosing, and patient education
 Occurs in response to a variety of allergens
 Vernal conjunctivitis refers to conjunctivitis that occurs primarily in the spring, usually
because of an allergen.
 The mast cell stabilizers (lodoxamide, cromolyn sodium) may be used to treat vernal
conjunctivitis and may be used safely for up to 3 months.
Treatment and Dosing
 Ketotifen (H1 blocker) for allergic conjunctivitis and ocular pruritus.
o The dose used in adults and children over age 3 is 1 drop in the affected eye every
8 to 12 hours

,  Levocabastine (H1 blocker): allergic conjunctivitis and ocular pruritis
o 1 drop in the affected eye 4 times a day.
 Mast Cell Stabilizers:
o Cromolyn sodium (1-2 gtt, 4-6 times/day)
o Pemirolast (Alamast), 1-2 gtts QID
o Nedocromil (Alocril), 1-2 gtts in each eye bid at regular intervals
 Antihistamines
o Antazoline-naphazoline (Vasocon-A), 1-3 gtts Q3-4 hours
o Azelastine (Optivar) 1 gtt each eye bid
o Epinastine (Elestat) 1 gtt each eye bid
o Emedastine (Emadine) 1 gtt QID
 OTC products
o Combine a decongestant with an antihistamine
o Products that combine antazoline and naphazoline (Vasocon-A) or
o Naphazoline and pheniramine (Opcon-A, Naphcon-A) 1-2 gtt q3-4 hrs

 Patient education
o Administration: use exactly as prescribed, overuse or underuse can adversely
affect outcomes
o Avoid touching the dropper to the ey or other surfaces that may contaminate the
medication
o Do not share medications
o Transient stinging and burning may occur
o If severe or prolonged contact provider



Bacterial conjunctivitis: Treatment, dosing, and pt education
 Children between ages 3 months and 8 years are most likely to have staphylococcal,
streptococcal, or Haemophilus conjunctivitis.
 Non-typable H. influenzae is seen more in warmer climates between May and October
o Most common in children younger than 7
 S. pneumoniae is seen in colder climates and during the winter (elderly)
 S. aureus shows no geographic or seasonal pattern (elderly)
 Although bacterial conjunctivitis is considered a self-limited disease (unless caused by
gonorrhea), patients who receive topical antibiotic therapy have faster clinical
improvement.

 Treatment and Dosing: Uncomplicated conjunctivitis treated with
o Sulfacetamide 10% solution or ointment:
 1-2 gtts q2-3 hrs during the day, less often at night

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller chinks. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $17.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

75057 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$17.49
  • (0)
  Add to cart